COMPANY

Notitia Biotechnologies

HQ: Monmouth Junction, NJ source · notitiabio.com ↗ · Mid-Atlantic

Keywords: microbiome Suspected or Confirmed COVID-19 NBT-NM108

Location: Monmouth Junction, NJ · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Nov 2, 2021 Trial start Phase 2: NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT04540406	NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients	Phase 2	Completed	Nov 2, 2021	Mar 14, 2022 (actual)